2022年中科院1区TOP

（1）Zheng L, Fang S, Chen A, Chen W, Qiao E, Chen M, Shu G, Zhang D, Kong C, Weng Q, Xu S, Zhao Z, Ji J. Piperlongumine synergistically enhances the antitumour activity of sorafenib by mediating ROS-AMPK activation and targeting CPSF7 in liver cancer. Pharmacol Res. 2022 Mar;177:106140. doi: 10.1016/j.phrs.2022.106140. Epub 2022 Feb 22. PMID: 35202819.影响因子10.334

（2）Tang B, Zhu J, Wang Y, Chen W, Fang S, Mao W, Xu Z, Yang Y, Weng Q, Zhao Z, Chen M, Ji J. Targeted xCT-mediated Ferroptosis and Protumoral Polarization of Macrophages Is Effective against HCC and Enhances the Efficacy of the Anti-PD-1/L1 Response. Adv Sci (Weinh). 2023 Jan;10(2):e2203973. doi: 10.1002/advs.202203973. Epub 2022 Nov 28. PMID: 36442849; PMCID: PMC9839855.影响因子17.521

（3）Tang B, Zhu J, Liu F, Ding J, Wang Y, Fang S, Zheng L, Qiu R, Chen M, Shu G, Xu M, Lu C, Zhao Z, Yang Y, Ji J. xCT contributes to colorectal cancer tumorigenesis through upregulation of the MELK oncogene and activation of the AKT/mTOR cascade. Cell Death Dis. 2022 Apr 19;13(4):373. doi: 10.1038/s41419-022-04827-4. PMID: 35440604; PMCID: PMC9019093.  影响因子9.696

（4）Shu G, Shen L, Ding J, Yu J, Chen X, Guo X, Qiao E, Chen Y, Lu C, Zhao Z, Du Y, Chen M, Ji J. Fucoidan-based dual-targeting mesoporous polydopamine for enhanced MRI-guided chemo-photothermal therapy of HCC via P-selectin-mediated drug delivery. Asian J Pharm Sci. 2022 Nov;17(6):908-923. doi: 10.1016/j.ajps.2022.08.004. Epub 2022 Oct 14. PMID: 36600896; PMCID: PMC9800939.  影响因子9.289